文献速递乳腺癌支持与姑息治疗

预防性使用压力袖套降低乳腺癌相关淋巴水肿高危女性手臂肿胀发生率:一项随机对照试验

Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
PubMed 文献 · J Clin Oncol · 2022-02-02

307例乳腺癌腋窝淋巴结清扫术后女性随机分为压力袖套组与对照组,压力袖套组术后佩戴至辅助治疗结束后3个月。基于生物阻抗光谱阈值,压力袖套组发生手臂肿胀的风险比为0.61(95%CI 0.43-0.85,P=.004),1年累积发生率42%对52%;基于相对手臂体积增加,风险比为0.56(95%CI 0.33-0.96,P=.034),1年累积发生率14%对25%。结论认为预防性使用压力袖套减少并延迟了术后第一年手臂肿胀的发生。

要点

  • 乳腺癌腋窝淋巴结清扫术后高危女性预防性佩戴压力袖套可降低手臂肿胀风险。
  • 基于生物阻抗光谱,压力袖套组手臂肿胀风险比为0.61(95%CI 0.43-0.85,P=.004)。
  • 基于相对手臂体积增加,压力袖套组手臂肿胀风险比为0.56(95%CI 0.33-0.96,P=.034)。

核心结论

  • 与对照组相比,预防性使用压力袖套减少并延迟了乳腺癌术后第一年淋巴水肿高危女性手臂肿胀的发生。

研究设计与样本

  • 随机对照试验,纳入307例因乳腺癌手术接受腋窝淋巴结清扫的女性,随机分为压力袖套组与对照组。
  • 压力袖套组在常规术后护理基础上接受两个压力袖套,术后佩戴至辅助治疗结束后3个月。
  • 手臂肿胀通过生物阻抗光谱阈值和相对手臂体积增加判定,采用Kaplan-Meier分析比较发生率和无肿胀时间。

主要发现

  • 基于生物阻抗光谱,压力袖套组相对于对照组发生手臂肿胀的风险比为0.61(95%CI 0.43-0.85,P=.004)。
  • 基于相对手臂体积增加,压力袖套组相对于对照组发生手臂肿胀的风险比为0.56(95%CI 0.33-0.96,P=.034)。
  • 基于生物阻抗光谱,1年时手臂肿胀估计累积发生率压力袖套组为42%,对照组为52%。
  • 基于相对手臂体积增加,1年时手臂肿胀估计累积发生率压力袖套组为14%,对照组为25%。
  • 从基线至EORTC QLQ-C30和BR23问卷四个量表首次达到最小重要差异的时间,风险比均无统计学意义。

关键数值与推荐

  • 手臂肿胀判定采用生物阻抗光谱阈值和相对手臂体积增加。
  • 基于生物阻抗光谱,压力袖套组相对于对照组发生手臂肿胀的风险比为0.61(95%CI 0.43-0.85,P=.004)。
  • 基于相对手臂体积增加,压力袖套组相对于对照组发生手臂肿胀的风险比为0.56(95%CI 0.33-0.96,P=.034)。

临床怎么用

  • 原文结论认为,对于乳腺癌术后淋巴水肿高危女性,预防性使用压力袖套可减少并延迟术后第一年手臂肿胀的发生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether prophylactic use of compression sleeves prevents arm swelling in women who had undergone axillary lymph node dissection for breast cancer surgery. METHODS: Women (n = 307) were randomly assigned to either a compression or control group. In addition to usual postoperative care, the compression group received two compression sleeves to wear postoperatively until 3 months after completing adjuvant treatments. Arm swelling was determined using bioimpedance spectroscopy (BIS) thresholds and relative arm volume increase (RAVI). Incidence and time free from arm swelling were compared using Kaplan-Meier analyses. Hazard ratios (HRs) were estimated from Cox regression models for BIS and RAVI thresholds independently. In addition, time to documentation of the first minimally important difference (MID) in four scales of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the breast cancer-specific (BR23) questionnaire was analyzed. RESULTS: The HR for developing arm swelling in the compression group relative to the control group was 0.61 (95% CI, 0.43 to 0.85; P = .004) on the basis of BIS and 0.56 (95% CI, 0.33 to 0.96; P = .034) on the basis of RAVI. The estimated cumulative incidence of arm swelling at 1 year was lower in the compression group than the control group on the basis of BIS (42% v 52%) and RAVI (14% v 25%). HRs for time from baseline to the first change of the minimally important difference were not statistically significant for any of the four scales of EORTC QLQ-30 and BR23 questionnaires. CONCLUSION: Prophylactic use of compression sleeves compared with the control group reduced and delayed the occurrence of arm swelling in women at high risk for lymphedema in the first year after surgery for breast cancer.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Paramanandam VS, Dylke E, Clark GM, et al. Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer-Related Lymphedema: A Randomized Controlled Trial. J Clin Oncol. 2022. PMID: 35108031. doi:10.1200/JCO.21.02567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。